Document:

Filed by OTC Filings Inc. - www.otcedgar.com - Cannabis Science, Inc. - Exhibti 10.1

 MANAGEMENT AGREEMENT
  
 THIS AGREEMENT (the "Agreement") effective as of the twentieth (20th) day of May 2013 (the “Effective Date”), entered into between Cannabis Science, Inc. a Nevada Corporation, with its principal offices located at 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 (the “Company” or “CBIS”) and IMMUNOCLIN LIMITED (a British company, owned 100% by Dr. Dorothy Helen Bray) with Limited with registered address at Rowlandson House, 289-293 Ballards Lane, London N12-8NP, United Kingdom(hereinafter, IMMUNOCLIN LIMITEDand its owner, Dr. Dorothy Helen Bray, are referred to as the “Consultant”) in connection with the provision of the Consultant’s services to the Company.
  
 WHEREAS:
  
 A.      The Company is in the business of developing, manufacturing, marketing, and distributing legal cannabinoid-based and other products, particularly pharmaceutical products, worldwide;
  
 B.      The Company wishes to engage the services of the Consultant as an independent contractor of the Company; and
  
 C.      The Company and the Consultant have agreed to enter into a consulting agreement for their mutual benefit.
  
 THIS AGREEMENT WITNESSES THAT in consideration of the premises and mutual covenants contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound hereby, agree as follows:
  
 1.         ENGAGEMENT AS A CONSULTANT
  
 1.1       The Company hereby engages the Consultant as an independent contractor of the Company, to undertake the duties and title of Member, Board of Directors, and to undertake the duties and title of Chief Executive Officer, and the Consultant agrees to exercise those powers as requested by the Company or its subsidiaries from time to time, (collectively the “Services”) and the Consultant accepts such engagement on the terms and conditions set forth in this Agreement.
  
 2.         TERM OF THIS AGREEMENT
  
 2.1       The term of this Agreement shall begin as of the Effective Date and shall continue for two (2) years or until terminated earlier pursuant to Sections 10 and 11 herein (the “Term”).  Any renewal period for this Agreement shall be at the sole discretion of the Company along with the renewal term including any compensation for services during the renewal term.
  
 3.         CONSULTANT SERVICES
  
 3.1              The Consultant shall undertake and perform the duties and responsibilities commonly associated with acting in the capacities of Director and Chief Executive Officer, including, but not limited to those duties attached hereto as Appendix “A”.   The Consultant agrees that his duties may be reasonably modified at the Company’s and the Consultant’s mutual agreement from time to time.
  
  	 1                 

	               

  
  
 3.2              In providing the Services the Consultant shall:
  
 ·         comply with all applicable local statutes, laws and regulations;
 ·         not make any misrepresentation or omit to state any material fact which results in a misrepresentation regarding the business of the Company; 
 ·         not disclose, release or publish any information regarding the Company without the prior written consent of the Company; and
 ·         not employ any person in any capacity, or contract for the purchase or rental of any service, article or material, nor make any commitment, agreement or obligation whereby the Company shall be required to pay any monies or other consideration without the Company's prior written consent. 
  
 4.         CONSULTANT COMPENSATION
  
 4.1              Fees.  As compensation for the provision of the Services, the Company shall pay the Consultant five thousand dollars ($5,000.00) per month, no later than 5 days after the end of each month.  In the event of non-payment, the Consultant will have right to terminate the Services.
  
 4.2              Shares and Options.  As further compensation for the provision of the Services, the Company shall pay the Consultant five million (5,000,000) newly issued Rule 144 restricted common shares of Company common stock, par value $0.001 per share. Shares will be issued within 2 weeks of signing the agreement.
  
 4.3              Performance Bonus.As further compensation based on job performance, product development and branding, product sales, achievement of project or operational milestones, the Company is committed to providing an additional bonus schedule for the Consultant. Such options will be agreed by both parties in writing.
  
 5.         NO REIMBURSEMENT OF EXPENSES
  
 5.1       The parties agree that the Compensation hereunder shall be inclusive of any and all fees or expenses incurred by the Consultant on the Consultant’s own behalf pursuant to this Agreement including but not limited to the costs of rendering the Services.  Notwithstanding the foregoing, the Company shall reimburse the Consultant for any bona fide expenses such as travel and telephone incurred by the Consultant on behalf of the Company in connection with the provision of the Services provided that the Consultant submits to the Company an itemized written account of such expenses and corresponding receipts of purchase in a form acceptable to the Company within 10 days after the Consultant incurs such expenses.  However, the Company shall have no obligation to reimburse the Consultant for any single expense in excess of $500 or $3,000.00 in the aggregate without the express prior written approval of the Company’s Board of Directors (agreement made by Dr Robert Melamede or Mr Raymond Dabney will be honoured).
  
 6.         CONFIDENTIALITY
  
 6.1       The Consultant shall not disclose to any third party without the prior consent of the Company any financial or business information concerning the business, affairs, plans and programs of the Company its Directors, officers, shareholders, employees, or consultants (the "Confidential Information").  The Consultant shall not be bound by the foregoing limitation in the event (i) the Confidential Information is otherwise disseminated and becomes public information or (ii) the Consultant is required to disclose the Confidential Informational pursuant to a subpoena or other judicial order.  As a material inducement to the Company entering into this Agreement, the Consultant shall, at the Company’s request, execute a confidentiality and non-disclosure agreement in a form mutually agreed upon by the Company and the Consultant.
  
  
  	 2                 

	               

 
 7.         GRANTS OF RIGHTS AND INSURANCE
  
 7.1       The Consultant agrees that the results and proceeds of the Services under this Agreement, although not created in an employment relationship, shall, for the purpose of copyright only, be deemed a work made in the course of employment under the Canadian law or a work-made-for-hire under the United States law and all other comparable international intellectual property laws and conventions.  All intellectual property rights and any other rights which the Consultant may have in and to any work, materials, or other results and proceeds of the Services hereunder shall vest irrevocably and exclusively with the Company and are otherwise hereby assigned to the Company as and when created.  The Consultant hereby waives any moral rights of authors or similar rights the Consultant may have in or to the results and proceeds of the Consulting Services hereunder.
 
7.2       For the avoidance of doubt, the Company will not have any rights to the intellectual property owned by IMMUNOCLIN LIMITED
  
 7.3       The Company shall have the right to apply for and take out, at the Company's expense, life, health, accident, or other insurance covering the Consultant, in any amount the Company deems necessary to protect the Company's interest hereunder.  The Consultant shall not have any right, title, or interest in or to such insurance.
  
 8.         REPRESENTATIONS AND WARRANTIES
  
 8.1       The Consultant represents, warrants and covenants to the Company as follows: 
  
 (a)    the Consultant is not under any contractual or other restriction which is inconsistent with the execution of this Agreement, the performance of the Services hereunder or any other rights of the Company hereunder;
  
 (b)   the Consultant is not under any physical or mental disability that would hinder the performance of his duties under this Agreement;
  
 (c)    The Company will provide and disclose all legal and commercial information to the Consultant that is necessary to perform Consultant’s duties
  
 9.         INDEMNIFICATION
  
 9.1       The Consultant shall indemnify and hold harmless the Company, its partners, financiers, parent, affiliated and related companies, and all of their respective individual shareholders, directors, officers, employees, licensees and assigns from and against any claims, actions, losses and expenses (including legal expenses) occasioned by any breach by the Consultant of any representations and warranties contained in, or by any breach of any other provision of, this Agreement by the Consultant.
  
 9.2       The Company shall indemnify and hold harmless the Consultant, its partners, financiers, parent, affiliated and related companies, and all of their respective individual shareholders, directors, officers, employees, licensees and assigns from and against any claims, actions, losses and expenses (including legal expenses) occasioned by any breach by the Company of any representations and warranties contained in, or by any breach of any other provision of, this Agreement by the Company.
 
 	 3           

	               

  
 10.        NO OBLIGATION TO PROCEED.  
  
 10.1     Nothing herein contained shall in any way obligate the Company to use the Services hereunder or to exploit the results and proceeds of the Services hereunder; provided that, upon the condition that the Consultant is not in material default of the terms and conditions hereof, nothing contained in this section 10.1 shall relieve the Company of its obligation to deliver to the Consultant the Compensation.  All of the foregoing shall be subject to the other terms and conditions of this Agreement (including, without limitation, the Company’s right of termination, disability and default).
  
 11.       RIGHT OF TERMINATION.  
  
 11.1      The Company and the Consultant shall each have the right to terminate this Agreement at any time in its sole discretion by giving not less than 30 days written notice. Upon termination of this Agreement all monies due to the contractors will be considered paid in full for the term the services were performed. Upon termination of this Agreement the Consultant shall continue to work with the Company to fulfill the obligations of this Agreement during the notice period and this period will be paid for per terms of this agreement.
  
 12.        DEFAULT/DISABILITY. 
  
 12.1      No act or omission of the Company hereunder shall constitute an event of default or breach of this Agreement unless the Consultant shall first notify the Company in writing setting forth such alleged breach or default and the Company shall cure said alleged breach or default within 10 days after receipt of such notice (or commence said cure within said ten days if the matter cannot be cured in ten days, and shall diligently continue to complete said cure).  Upon any material breach or de­fault by the Consultant of any of the terms and conditions hereof, or the terms and conditions of any other agreement between the Company and the Consultant for the services of the Consultant, the Consultant may cure said alleged breach or default within 10 days after receipt of such notice (or commence said cure within said ten days if the matter cannot be cured in ten days, and shall diligently continue to complete said cure), or the Company shall immediately have the right to suspend or to terminate this Agreement and any other agreement between the Company and the Consultant for the services of the Consultant.  
  
 13.        COMPANY'S REMEDIES.  
  
 13.1      The services to be rendered by the Consultant hereunder and the rights and privileges herein granted to the Company are of a special, unique, unusual, extraordinary and intellectual character which gives them a peculiar value, the loss of which cannot be reasonably or adequately compensated in damages in an action at law, it being understood and agreed that a breach by the Consultant of any of the provisions of this Agreement shall cause the Company irreparable injury and damages.  The Consultant expressly agrees that the Company shall be entitled to seek injunctive and/or other equitable relief to prevent a breach hereof the Consultant.  Resort to such equitable relief, however, shall not be construed as a waiver of any other rights or remedies which the Company may have in the premises for damages or otherwise.
  
 14.       INDEPENDENT CONTRACTORS.  
  
 14.1     Nothing herein shall be construed as creating a partnership, joint venture, or master-servant relationship between the parties for any purpose whatsoever.  Except as may be expressly provided herein, neither party may be held responsible for the acts either of omission or commission of the other party, and neither party is authorized, or has the power, to obligate or bind the other party by contract, agreement, warranty, representation or otherwise in any manner.  It is expressly understood that the relationship between the parties is one of independent contractors. 
  
 	 4                 

	               

 15.       MISCELLANEOUS PROVISIONS
  
 (a)    Time.  Time is of the essence of this Agreement.
  
 (b)   Presumption.  This Agreement or any section thereof shall not be construed against any party due to the fact that said Agreement or any section thereof was drafted by said party.
  
 (c)    Titles and Captions.  All article, section and paragraph titles or captions contained in this Agreement are for convenience only and shall not be deemed part of the context nor affect the interpretation of this Agreement.
  
 (d)   Further Action.  The parties hereto shall execute and deliver all documents, provide all information and take or forbear from all such action as may be necessary or appropriate to achieve the purposes of this Agreement.
  
 (e)    Savings Clause.  If any provision of this Agreement, or the application of such provision to any person or circumstance, shall be held invalid, the remainder of this Agreement, or the application of such provision to persons or circumstances other than those as to which it is held invalid, shall not be affected thereby.
  
 (f)    Assignment.  The Company may assign this Agreement, in whole or in part, at any time to any party, as the Company shall determine in its sole discretion; pro­vided that, no such assignment shall relieve the Company of its obligations hereunder unless consented to by the Consultant in writing.  The Consultant may assign this Agreement with the prior written consent of the Company. 

 (g)   Notices.  All notices required or permitted to be given under this Agreement shall be given in writing and shall be delivered, either personally or by express delivery service, to the party to be notified.  Notice to each party shall be deemed to have been duly given upon delivery, personally or by courier, addressed to the attention of the officer at the address set forth heretofore, or to such other officer or addresses as either party may designate, upon at least ten days written notice, to the other party. 
  
 (h)   Entire agreement.  This Agreement contains the entire understanding and agreement among the parties.  There are no other agreements, conditions or representations, oral or written, express or implied, with regard thereto.  This Agreement may be amended only in writing signed by all parties.
  
 (i)     Waiver.  A delay or failure by any party to exercise a right under this Agreement, or a partial or single exercise of that right, shall not constitute a waiver of that or any other right.
  
 (j)     Counterparts.  This Agreement may be executed in duplicate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same Agreement.
  
 (k)   Successors.  The provisions of this Agreement shall be binding upon all parties, their successors and permitted assigns. 
  
 (l)     Counsel.  The parties expressly acknowledge that each has been advised to seek separate counsel for advice in this matter and has been given a reasonable opportunity to do so.
  
    	 5                 

	               

   
  
 IN WITNESS WHEREOF, the parties have duly executed and delivered this Agreement as of the date first written above.
  
  
 CANNABIS SCIENCE, INC.                                                         
 Per:                                                                                                      
  
 /s/ Robert Melamede
 _____________________________                                                  
 Robert Melamede, Ph.D., President     
  
  
 /s/ Chad S. Johnson
 ________________________________
 Chad S. Johnson, Esq., COO, Director                                                
  
   
  
 CONSULTANT:
 By:

/s/ Dr. Dorothy Helen Bray
______________________________
 Dr. Dorothy Helen Bray, Owner
 IMMUNOCLIN LIMITED
  
  
  	 6                 

	               

 
 APPENDIX “A”
  
 Consultant’s duties include, but are not limited to the following:
  
 Position Overview
  
 A Member of the Board of Directors serves as an advisor and counselor to Executive Management on the Company’s strategy and performance and provides ongoing governance of the Company.  The Chief Executive Officer (CEO) is the highest-ranking member of the Executive Management of the Company. 
  
 General Responsibilities and Duties as Chief Executive Officer 
 1.  Develop and implement high-level strategies
 2.  Make major corporate decisions
 3.  Manage the overall operations and resources of the Company
 4.  Act as the main point of communication between the Board of Directors and the corporate operations
 General Responsibilities and Duties as Member, Board of Directors
 1.  Work with the senior management team to ensure appropriate strategic and effective organizational planning
 2.  Review regularly and amend or update the Company’s strategic direction and goals
 3.  Ensure that an appropriate set of internal controls are implemented and reviewed regularly
 4.  Support and evaluate the Chief Executive Officer with the goals of the Company in mind 
 5.  Appraise, advise, support, reward, and, when necessary, change top management
 6.  Determine that the Company’s programs are consistent with its mission and monitoring the effectiveness of these programs
 7.  Assist in securing adequate financial resources for the organization to fulfill its mission 
 8.  Review and approve of the Company’s plans for funding strategies on an annual basis
 9.  Assure the financial structure of the Company is adequate for its current needs and its long-range strategy
 10. Define prerequisites for potential new board members, orienting these new members, and periodically evaluating performance
 11. Adhere to legal and ethical standards and norms
 12. Develop, amend and approve by-laws and governing policies 
 13. Ensure robust and effective risk and compliance management and control systems (including legal compliance) are in place and operating effectively
 14. Oversee the control and accountability systems that ensure the Company is progressing towards the goals set by the Board and in line with the Company’s purpose, the agreed corporate strategy and legislative requirements 
   	 710.1

Exhibit 10.1

REORGANIZATION AGREEMENT 

This REORGANIZATION AGREEMENT dated as of June 10, 2013 (this “Agreement”) is by and between Pronto Corp., Inc. a Nevada company  (“Pronto”) located at 909 Bay Street, Suite 812, Toronto, Ontario, Canada M5S 3G2, and RAR Beauty, LLC. (“RAR”) a Florida Limited Liability Company.   RAR and Pronto are collectively referred to herein as the “Parties”.

WHEREAS, the respective boards of directors of each of RAR and Pronto have approved the acquisition of RAR by Pronto (the “Acquisition”) upon the terms, and subject to the conditions, set forth in this Agreement;

WHEREAS, it is intended that, for federal income tax purposes, the Acquisition shall qualify as a reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated there under (the “Code”); and

WHEREAS, RAR and Pronto desire to make certain representations, warranties, covenants and agreements in connection with this Agreement.

WHEREAS, Pronto desires to acquire 100% of the issued and outstanding stock of RAR;

NOW, THEREFORE, The Boards of Directors of Pronto and RAR deem it advisable and in their best interests that the shareholders of RAR acquire approximately a 75% controlling interest in the securities of Pronto, and Pronto acquire a 100% controlling interest in the securities of RAR, in accordance with the terms and conditions of this Reorganization Agreement.

1.

Pre-Closing Actions of Pronto.  Either prior to or immediately upon execution of this Agreement and prior to any Closing as set forth herein, Pronto shall undertake the following actions:

(a)

The Board of Directors of Pronto shall unanimously approve and deliver to Lanham & Lanham, LLC ("Escrow") in escrow resolutions with respect to (a) approving the Transactions set forth herein; (b) increasing or directing the size of the Board of Directors to be three members; (c) electing three persons designated by RAR to the Board of Directors, and (d) approving a name change of the corporation to “RAR Beauty, Inc.”

(b)

Pronto shall prepare and deliver to counsel for RAR for review a Form 8-K filing which reflects the transactions contemplated by this Agreement, as required to be filed with the Securities and Exchange Commission (the “Commission”) on the Closing Date (defined below) 

(c)

Pronto shall either complete a full dilution of all issued and outstanding notes, convertible debentures, warrants and/or options of its common stock or cancel or cause to be cancelled all those not exercised into shares of its common stock such that at Closing there shall be a total of approximately 60,000,000 shares of common stock issued and outstanding (including the Escrowed Pronto Shares).

(d)

Pronto shall issue and deliver to Lanham & Lanham, LLC as Escrow (the “Escrow Agent”) for a total of approximately 45,000,000 shares of common stock of Pronto (which at the time of Closing will reflect approximately 75% of the fully diluted issued and outstanding common stock of Pronto) for delivery to members of RAR at Closing (the "Escrowed Pronto Shares").  

(e)

Pronto will deliver letters of resignation of Pronto’s current officers and directors to be effective at the Closing Date, unless new officers and directors have been appointed prior to the Closing Date pursuant to this Agreement;

(f)

Pronto shall use its reasonable best efforts to prepare and complete the documents necessary to be filed with local, state and federal authorities to consummate the transactions contemplated hereby.

(g)

Financing – Pronto shall provide to RAR a total of Three Million, five hundred thousand US dollars ($3,500,000) over a period of two (2) years.  The first eight hundred thousand US dollars ($800,000) shall be provided within forty-five (45) days of signing this Agreement and shall be utilized as follows: five hundred thousand ($500,000) shall be considered a down payment on the purchase price and three hundred thousand ($300,000) shall be working capital (“Working Capital”).  Said Working Capital shall be used to complete this business combination including, but not limited to, an audit, filings, transfer agent fees and all necessary filings with the Securities and Exchange Commission.  The balance of two million five hundred thousand US dollars ($2,500,000) shall be provided of the next twenty-four (24) months.  Further, it is hereby agreed that RAR has debt in the amount of approximately five hundred thousand dollars ($500,000) that shall be retired upon completion of this business combination.

(h)

It is hereby agreed that all funds raised in the above Financing shall be contributed by third parties and not Pronto directly.  If said Financing funds are not raised in accordance with paragraph (g) above, RAR in no way holds Pronto or its current management responsible and hereby grants to them hold harmless provisions as to the Financing.

(i)

Super Voting Rights.  It is hereby agreed that Seller’s management shares shall have “super voting rights.”  Whereby, each share owned by management, when voted at an annual meeting of shareholders, shall be counted as twenty (20) votes.  A list of individuals who qualify as “Management” shall be provided by the Seller.  

2.

Pre-Closing Actions of RAR.  Immediately upon execution of this Agreement and prior to the Closing as set forth herein, RAR shall undertake the following actions:

(a)

RAR shall cause its Board of Directors to execute and deliver resolutions approving the Transactions set forth herein.

(b)

RAR shall deliver to Lanham & Lanham, LLC as Escrow (the “Escrow Agent”) share certificates of the Company shares that represents 100% of the equity of RAR, for delivery to Pronto at Closing (the "Escrowed RAR Shares").

(c)

RAR shall complete and deliver to Pronto a complete audit of its financial statements, including any interim or other financial statements required for inclusion in the Form 8-K filing to be completed at Closing, (the “RAR Financial Statements”).

(d)

RAR shall cooperate with its reasonable best efforts to assist Pronto to prepare and complete the documents necessary to be filed with local, state and federal authorities to consummate the transactions contemplated hereby.

(e)

RAR shall deliver to Escrow Agent the sum of $150,000 USD as part of the transaction.  These funds shall be delivered to bring the POTO balance sheet to zero – zero balance.

3.

Conditions to Closing.  The parties' obligation to close the proposed Acquisition will be subject to specified conditions precedent including, but not limited to, the following:

(a)

the representations and warranties of RAR as set forth in Section 6 herein shall remain accurate as of the Closing Date and no material adverse change in the business of RAR shall have occurred; 

(b)

the representations and warranties of Pronto as set forth in Section 7 herein shall remain accurate as of the Closing Date and no material adverse change in the business of Pronto shall have occurred; 

(c)

all the documents necessary to be filed with local, state and federal authorities are prepared 

(d)

Pronto shall have provided the board resolutions and any other approval required to complete the board election and the name change.

(e)

Pronto shall retain its good standing as a publicly company is quoted on the OTCBB under the symbol "Pronto".

(f)

Reverse Split.

It is hereby agreed that neither Party shall agree to a reverse split of the shares of the public company for a period of three (3) years from the Closing.

(g)

Upon delivery of shares certificates to RAR, the Escrow Agent shall deliver to POTO the sum of $150,000 USD.  As stated in paragraph 2(e) above.

4.

At the Closing.

(a)

At the Closing, Lanham & Lanham, LLC shall release from escrow letters of resignation and the Pronto Board Resolutions effectuating the election of three new members of the Board of Directors.

(b)

At the Closing, Lanham & Lanham, LLC shall deliver the Escrowed Pronto Shares to RAR for delivery to members of RAR.

(c)

At the Closing, Lanham & Lanham, LLC shall deliver the Escrowed RAR Shares to Pronto.

(d)

At the Closing, the existing officers of Pronto shall resign and be replaced by those officers appointed by the new Board of Directors.

(f)

Immediately subsequent to the Closing, the combined entities will file the Form 8-K required for the transactions contemplated by this Agreement.

5.

Timing of Closing.  The Closing is anticipated to occur within 10 days of this Agreement, but shall occur upon the satisfaction of the conditions set forth in this Agreement and upon instructions from the parties hereto to the Escrow Agent.  The Closing Date shall occur as soon as possible after the execution of this Agreement and upon completion of the amendment to the Articles of Incorporation, unless the Escrow Agent receives instructions otherwise from the parties or notice from a party that the conditions set forth herein have not occurred.  In the event the Closing does not occur on or before July 31, 2013, (i) the Escrow Agent shall return the Escrowed RAR Shares to RAR and (ii) the Escrow Agent shall return the Escrowed Pronto Shares.

6.

Representations of RAR.  Except as set forth in the RAR Financial Statements delivered as set forth in Section 2(c) above, RAR represents and warrants as follows:

(a)

Ownership of Shares.  As of the Closing Date, Pronto will become the record and beneficial owner of the Escrowed RAR Shares.  The Escrowed RAR Shares will be free from claims, liens or other encumbrances, except as provided under applicable federal and state securities laws and pursuant to a Shareholders Agreement of even date herewith between Pronto and the remaining two RAR shareholders.  The Escrowed RAR Shares shall reflect 100% of the ownership equity of RAR.

(b)

Fully paid and Nonassessable.  The Escrowed RAR Shares constitute duly and validly issued ownership interests of RAR, and are fully paid and nonassessable, and RAR further represents that it has the power and the authority to execute this Agreement and to perform the obligations contemplated hereby;

(c)

Organization of RAR; Authorization.  RAR is a limited liability company duly organized, validly existing and in good standing under the laws of the State of Florida with full corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder. The execution, delivery and performance of this Agreement have been duly authorized by all necessary corporate action and this Agreement constitutes a valid and binding obligation of RAR; enforceable against it in accordance with its terms.  Except as set forth on Schedule 6(c), RAR has no subsidiaries.

(d)

Capitalization.  As of the Closing Date, RAR has a total of 200 shares issued and outstanding.  All of the issued and outstanding shares of RAR are validly issued, fully paid and non-assessable and there is not and as of the Closing Date there will not be outstanding any warrants, options or other agreements on the part of any of RAR obligating such entity to issue any additional shares of common or preferred stock, any ownership interest or any of its securities of any kind.

 (e)

No Conflict as to RAR.  Neither the execution and delivery of this Agreement nor the consummation of the exchange of the Escrowed RAR Shares will (a) violate any provision of the membership agreement or by-laws (or other governing instrument) of RAR or (b) violate, or be in conflict with, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination of, or accelerate the performance required by, or excuse performance by any Person of any of its obligations under, or cause the acceleration of the maturity of any debt or obligation pursuant to, or result in the creation or imposition of any Encumbrance upon any property or assets of RAR under, any material agreement or commitment to which RAR is a party or by which its property or assets is bound, or to which any of the property or assets of RAR is subject, or (c) violate any statute or law or any judgment, decree, order, regulation or rule of any court or other Governmental Body applicable to RAR except, in the case of violations, conflicts, defaults, terminations, accelerations or encumbrances described in clause (b) of this Section for such matters which are not likely to have a material adverse effect on the business or financial condition of RAR.

(f)

Consents and Approvals of Governmental Authorities. No consent, approval or authorization of, or declaration, filing or registration with, any Governmental Body is required to be made or obtained by RAR in connection with the execution, delivery and performance of this Agreement by RAR or the consummation of the sale of the Escrowed RAR Shares.

(g)

Other Consents. No consent of any Person is required to be obtained by RAR to the execution, delivery and performance of this Agreement or the consummation of the sale of the Escrowed RAR Shares, including, but not limited to, consents from parties to leases or other agreements or commitments, except for any consent which the failure to obtain would not be likely to have a material adverse effect on the business and financial condition of RAR as a whole.

(h)

Litigation.  There is no action, suit, inquiry, proceeding or investigation by or before any Court or Governmental body pending or threatened in writing against or involving RAR which is likely to have a material adverse effect on the business or financial condition of RAR as a whole, or which questions or challenges the validity of this Agreement.  RAR is not subject to any judgment, order or decree that is likely to have a material adverse effect on the business or financial condition of RAR as a whole.

(i)

Absence of Certain Changes. RAR has not:

1.

suffered the damage or destruction of any of its properties or assets (whether or not covered by insurance) which is materially adverse to the business or financial condition, or made any disposition of any of its material properties or assets other than in the ordinary course of business;

2.

made any change or amendment in its certificate of incorporation or by-laws, or other governing instruments;

3.

other than the RAR Escrowed Shares, issued or sold any Equity Securities or other securities, acquired, directly or indirectly, by redemption or otherwise, any such Equity Securities, reclassified, split-up or otherwise changed any such Equity Security, or granted or entered into any options, warrants, calls or commitments of any kind with respect thereto; 

4.

organized any new Subsidiary or acquired any Equity Securities of any Person or any equity or ownership interest in any business; 

5.

borrowed any funds or incurred, or assumed or become subject to, whether directly or by way of guarantee or otherwise, any obligation or liability with respect to any such indebtedness for borrowed money;  

6.

paid, discharged or satisfied any material claim, liability or obligation (absolute, accrued, contingent or otherwise), other than in the ordinary course of business;

7.

prepaid any material obligation having a maturity of more than 90 days from the date such obligation was issued or incurred;

8.

cancelled any material debts or waived any material claims or rights, except in the ordinary course of business;  

9.

disposed of or permitted to lapse any rights to the use of any material patent or registered trademark or copyright or other intellectual property owned or used by it;

10.

sold, transferred or otherwise disposed of any material assets, including without limitation technology and intangible assets;

11.

granted any general increase in the compensation of officers or employees (including any such increase pursuant to any employee benefit plan);

(j)

Compliance with Law. The operations of RAR have been conducted in accordance with all applicable laws and regulations of all Governmental Bodies having jurisdiction over them, except for violations thereof which are not likely to have a material adverse effect on the business or financial condition of RAR as a whole.  RAR has not received any notification of any asserted present or past failure by it to comply with any such applicable laws or regulations.  RAR has all material licenses, permits, orders or approvals from the Governmental Bodies required for the conduct of its business, and is not in material violation of any such licenses, permits, orders and approvals.  All such licenses, permits, orders and approvals are in full force and effect, and no suspension or cancellation of any thereof has been threatened.

(k)

Title to Properties.  RAR owns all the material properties and assets that it purports to own (real, personal and mixed, tangible and intangible), including, without limitation, all the material properties and assets reflected in the RAR Financial Statements.  All properties and assets, including without limitation technology and intangible assets, are free and clear of all material encumbrances and are not, in the case of real property, subject to any material rights of way, building use restrictions, exceptions, variances, reservations or limitations of any nature whatsoever except, with respect to all such properties and assets, (a) mortgages or security interests shown on the RAR Financial Statements as securing specified liabilities or obligations, with respect to which no default (or event which, with notice or lapse of time or both, would constitute a default) exists, (b) mortgages or security interests incurred in connection with the purchase of property or assets after the date of such financial statements (such mortgages and security interests being limited to the property or assets so acquired), with respect to which no default (or event which, with notice or lapse of time or both, would constitute a default) exists, (c) as to real property, (i) imperfections of title, if any, none of which materially detracts from the value or impairs the use of the property subject thereto, or impairs the operations of RAR as a whole and (ii) zoning laws that do not impair the present or anticipated use of the property subject thereto, and (d) liens for current taxes not yet due.  The properties and assets of RAR include all rights, properties and other assets necessary to permit RAR to conduct business in all material respects in the same manner as it is conducted on the date of this Agreement.

7.

Representations of Pronto. Pronto for its respective rights and interests represents and warrants as follows:

(a)

Organization; Authorization.  Pronto is a corporation duly organized, validly existing and in good standing under the laws of Nevada with full corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder. The execution, delivery and performance of this Agreement have been duly authorized by all necessary corporate action of Pronto and this Agreement constitutes a valid and binding obligation; enforceable against in accordance with its terms.  Pronto has no subsidiaries.

(b)

Capitalization.  The authorized capital stock of Pronto consists of 75,000,000 shares of common stock, par value $0.001 per share, and 0 shares of preferred stock, par value $0.001 per share, authorized.  As of the date of this Agreement, Pronto has 3,450,000 shares of common stock issued and outstanding and no shares of preferred stock issued and outstanding.  As of the Closing Date, Pronto shall have no more than 60,000,000 shares of common stock outstanding (including the Pronto Escrowed Shares), and no preferred shares.  No shares have otherwise been registered under state or federal securities laws.  As of the Closing Date, all of the issued and outstanding shares of common stock of Pronto are validly issued, fully paid and non-assessable and, there is not and as of the Closing Date there will not be outstanding any warrants, options or other agreements on the part of Pronto obligating any of Pronto to issue any additional shares of common or preferred stock or any of its securities of any kind, except for such shares or securities called for in this Agreement.  The Common Stock of Pronto is presently quoted on the over-the-counter bulletin board under the symbol “Pronto”.  Pronto is current in all of its required filings with the US Securities and Exchange Commission.

(c)

No Conflict as to Pronto and Subsidiaries.  Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated herein will (a) violate any provision of the articles of incorporation or organization of Pronto or any of its Subsidiaries or (b) violate, or be in conflict with, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination of, or accelerate the performance required by, or excuse performance by any Person of any of its obligations under, or cause the acceleration of the maturity of any debt or obligation pursuant to, or result in the creation or imposition of any Encumbrance upon any property or assets of any of Pronto or any of its Subsidiaries under, any material agreement or commitment to which any of Pronto, any of its Subsidiaries is a party or by which any of their respective property or assets is bound, or to which any of the property or assets of any of Pronto or any of its Subsidiaries is subject, or (c) violate any statute or law or any judgment, decree, order, regulation or rule of any court or other Governmental Body applicable to Pronto or any of its Subsidiaries except, in the case of violations, conflicts, defaults, terminations, accelerations or Encumbrances described in clause (b) of this Section for such matters which are not likely to have a material adverse effect on the business or financial condition of  Pronto and its subsidiaries, taken as a whole.

(d)

Consents and Approvals of Governmental Authorities. Except with respect to a Form 8-K filing with the US Securities and Exchange Commission, no consent, approval or authorization of, or declaration, filing or registration with, any Governmental Body is required to be made or obtained by Pronto in connection with the execution, delivery and performance of this Agreement by Pronto or the consummation of the transactions contemplated herein.

(e)

Other Consents. No consent of any Person is required to be obtained by Pronto to the execution, delivery and performance of this Agreement or the consummation of the transactions contemplated herein, including, but not limited to, consents from parties to leases or other agreements or commitments, except for any consent which the failure to obtain would not be likely to have a material adverse effect on the business and financial condition of Pronto.

 (f)

Litigation.  There is no action, suit, inquiry, proceeding or investigation by or before any court or Governmental Body pending or threatened in writing against or involving Pronto or any of its Subsidiaries which is likely to have a material adverse effect on the business or financial condition of Pronto and any of its Subsidiaries, taken as whole, or which would require a payment by Pronto or its subsidiaries in excess of $10,000 in the aggregate or which questions or challenges the validity of this Agreement. Neither Pronto nor any or its Subsidiaries is subject to any judgment, order or decree that is likely to have a material adverse effect on the business or financial condition of Pronto or any of its Subsidiaries, taken as a whole, or which would require a payment by Pronto or its Subsidiaries in excess of $10,000 in the aggregate.

(g)

Absence of Certain Changes. Neither Pronto nor any of its Subsidiaries has:

1.

suffered the damage or destruction of any of its properties or assets (whether or not covered by insurance) which is materially adverse to the business or financial condition of  Pronto and its Subsidiaries, taken as a whole, or made any disposition of any of its material properties or assets other than in the ordinary course of business;

2.

made any change or amendment in its certificate of incorporation or by-laws, or other governing instruments;

3.

paid, discharged or satisfied any material claim, liability or obligation (absolute, accrued, contingent or otherwise), other than in the ordinary course of business;  

4.

prepaid any material obligation having a maturity of more than 90 days from the date such obligation was issued or incurred;  

5.

cancelled any material debts or waived any material claims or rights, except in the ordinary course of business;  

6.

disposed of or permitted to lapse any rights to the use of any material patent or registered trademark or copyright or other intellectual property owned or used by it;  

7.

granted any general increase in the compensation of officers or employees (including any such increase pursuant to any employee benefit plan);  

8.

purchased or entered into any contract or commitment to purchase any material quantity of raw materials or supplies, or sold or entered into any contract or commitment to sell any material quantity of property or assets, except (i) normal contracts or commitments for the purchase of, and normal purchases of, raw materials or supplies, made in the ordinary course business, (ii) normal contracts or commitments for the sale of, and normal sales of, inventory in the ordinary course of business, and (iii) other contracts, commitments, purchases or sales in the ordinary course of business;  

9.

written off or been required to write off any notes or accounts receivable in an aggregate amount in excess of  $2,000;  

10.

written down or been required to write down any inventory in an aggregate amount in excess of  $ 2,000;  

11.

entered into any collective bargaining or union contract or agreement; or  

12.

other than the ordinary course of business, incurred any liability required by generally accepted accounting principles to be reflected on a balance sheet and material to the business or financial condition of Pronto and their subsidiaries taken as a whole.

 (h)

Compliance with Law. The operations of Pronto and its Subsidiaries have been conducted in accordance with all applicable laws and regulations of all Governmental Bodies having jurisdiction over them, except for violations thereof which are not likely to have a material adverse effect on the business or financial condition of Pronto and its Subsidiaries, taken as a whole, or which would not require a payment by Pronto or its Subsidiaries in excess of $2,000 in the aggregate, or which have been cured. Neither Pronto nor any of its Subsidiaries has received any notification of any asserted present or past failure by it to comply with any such applicable laws or regulations.  Pronto and its Subsidiaries have all material licenses, permits, orders or approvals from the Governmental Bodies required for the conduct of their businesses, and are not in material violation of any such licenses, permits, orders and approvals. All such licenses, permits, orders and approvals are in full force and effect, and no suspension or cancellation of any thereof has been threatened.

8.

Noncircumvention.  It is understood that in connection with the transactions contemplated hereby, RAR has been and will be seeking to find investors willing to provide loans and/or capital investments to finance business plans.  In connection therewith, Pronto will not, and it will cause its directors, officers, employees, agents and representatives not to attempt, directly or indirectly, (i) to contact any party introduced to it by RAR, or (ii) deal with, or otherwise become involved in any transaction with any party which has been introduced to it by RAR, without the express written permission of the introducing party and without having entered into a commission agreement with the introducing party.  Any violation of the covenant shall be deemed an attempt to circumvent RAR, and the party so violating this covenant shall be liable for damages in favor of the circumvented party.

9.

No Solicitations.  From and after the date of this Agreement until the Closing Date or termination of this Agreement pursuant, neither Pronto nor RAR will nor will it authorize or permit any of its officers, directors, affiliates or employees or any investment banker, attorney or other advisor or representative retained by it, directly or indirectly, (i) solicit or initiate the making, submission or announcement of any other acquisition proposal, (ii) participate in any discussions or negotiations regarding, or furnish to any person any non public information with respect to any other acquisition proposal, (iii) engage in discussions with any Person with respect to any other acquisition proposal, except as to the existence of these provisions, (iv) approve, endorse or recommend any other acquisition proposal or (v) enter into any letter of intent or similar document or any contract agreement or commitment contemplating or otherwise relating to any other acquisition proposal.

10.

Notices.  Any notice which any of the parties hereto may desire to serve upon any of the other parties hereto shall be in writing and shall be conclusively deemed to have been received by the party at its address, if mailed, postage prepaid, United States mail, registered, return receipt requested, to the following addresses:

If to RAR:

RAR Beauty, LLC

Attn:  

Telephone:  

Facsimile:

With a copy to:

Lanham & Lanham, LLC

28562 Oso Parkway, Unit D

Rancho Santa Margarita, CA 92688

Telephone:  (949) 933-1964

If to Pronto:

c/o Svetlana Gofman

909 Bay Street, Suite 812

Toronto, Ontario, Canada M5S 3G2

Telephone: (543) 513-7579

11.

Successors.  This Agreement shall be binding upon and inure to the benefit of the heirs, personal representatives and successors and assigns of the parties.

12.

Choice of Law.  This Agreement shall be construed and enforced in accordance with the laws of the State of Nevada, and the parties submit to the exclusive jurisdiction of the courts of Nevada in respect of all disputes arising hereunder.

13.

Counterparts.  This Agreement may be signed in one or more counterparts, all of which taken together shall constitute an entire agreement.

14.

Confidential Information.  Each of RAR and Pronto hereby acknowledges and agrees that all information disclosed to each other whether written or oral, relating to the other’s business activities, its customer names, addresses, all operating plans, information relating to its existing services, new or envisioned products or services and the development thereof, scientific, engineering, or technical information relating to the others business, marketing or product promotional material, including brochures, product literature, plan sheets, and any and all reports generated to customers, with regard to customers, unpublished list of names, and all information relating to order processing, pricing, cost and quotations, and any and all information relating to relationships with customers, is considered confidential information, and is proprietary to, and is considered the invaluable trade secret of such party (collectively “Confidential Information”).  Any disclosure of any Confidential Information by any party hereto, its employees, or representatives shall cause immediate, substantial, and irreparable harm and loss to the other.  Each party understands that the other desires to keep such Confidential Information in the strictest confidence, and that such party’s agreement to do so is a continuing condition of the receipt and possession of Confidential Information, and a material provision of this agreement, and a condition that shall survive the termination of this Agreement.  Consequently, each party shall use Confidential Information for the sole purpose of performing its obligations as provided herein. 

15.

Entire Agreement.  This Agreement and the Shareholders Agreement sets forth the entire agreement and understanding of the Parties hereto with respect to the transactions contemplated hereby, and supersedes all prior agreements, arrangements and understandings related to the subject matter hereof.  No understanding, promise, inducement, statement of intention, representation, warranty, covenant or condition, written or oral, express or implied, whether by statute or otherwise, has been made by any Party hereto which is not embodied in this Agreement or the written statements, certificates, or other documents delivered pursuant hereto or in connection with the transactions contemplated hereby, and no party hereto shall be bound by or liable for any alleged understanding, promise, inducement, statement, representation, warranty, covenant or condition not so set forth.

16.

Costs and Expenses.  Except as otherwise specifically set forth herein, each party will bear its own attorneys, brokers, investment bankers, agents, and finders employed by, such party.  The parties will indemnify each other against any claims, costs, losses, expenses or liabilities arising from any claim for commissions, finder's fees or other compensation in connection with the transactions contemplated herein which may be asserted by any person based on any agreement or arrangement for payment by the other party.

17.

Attorney’s Fees.  Should any action be commenced between the parties to this Agreement concerning the matters set forth in this Agreement or the right and duties of either in relation thereto, the prevailing party in such Action shall be entitled, in addition to such other relief as may be granted, to a reasonable sum as and for its Attorney’s Fees and Costs.

18.

Finders.  RAR and Pronto represents and warrants that there are no finders or other parties which have represented RAR or Pronto in connection with this transaction which have not received appropriate compensation.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

For and on behalf of:

Pronto Corp.

A Nevada Corporation

By:  /s/ Svetiana Gofman ______

Svetiana Gofman, President/CEO

For and on behalf of:

RAR Beauty, LLC

a Florida Limited Liability Company

By: /s/ Richard Roer ___________

Richard Roer, President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]